Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.

@article{Fialho2016SmallIB,
  title={Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.},
  author={Andr{\'e}a BC Fialho and Andr{\'e}a BC Fialho and Prashanthi N. Thota and Arthur J. McCullough and Bo Shen},
  journal={Journal of gastrointestinal and liver diseases : JGLD},
  year={2016},
  volume={25 2},
  pages={
          159-65
        }
}
  • A. Fialho, A. Fialho, B. Shen
  • Published 1 June 2016
  • Medicine, Biology
  • Journal of gastrointestinal and liver diseases : JGLD
BACKGROUND Changes in gut bacteria play a role in type 2 diabetes mellitus (DM) and hepatic steatosis. There is a lack of studies evaluating the frequency and risk factors for non-alcoholic fatty liver disease (NAFLD) in patients tested for small intestinal bacterial overgrowth (SIBO). AIM To evaluate the frequency of NAFLD and associated risk factors in patients tested for SIBO. METHODS In this case-control study, 372 eligible patients submitted to glucose hydrogen/methane breath test for… 

Figures and Tables from this paper

Association of small intestinal bacterial overgrowth and non-alcoholic fatty liver disease in children

It has been found that non-alcoholic fatty liver disease is a risk factor for SIBO development and SIBO was associated with low-grade inflammation and adverse metabolic profile.

PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.

Serum endotoxin levels did not differ between patients with and without SIBO, nor did these levels change after antibacterial therapy, virtually ruling out the possibility that elevated endotoxinemia in non-cirrhotic patients with NAFLD is associated with SIBO.

The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents

Obese children with SIBO have an increased risk for developing nonalcoholic fatty liver disease and the relationship between intestinal dysbiosis and diet can influence the gut-liver axis, according to this study.

Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis

It has been suggested that small intestinal bacterial overgrowth (SIBO) could cause nonalcoholic fatty liver disease (NAFLD), but this association was not examined in children by meta-analysis. This

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis

A significant association between NAFLD and SIBO was observed in this meta-analysis and funnel plot is relatively symmetric and is not suggestive of the presence of publication bias.

Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture

Low-grade bacterial overgrowth, particularly with Gram negative bacteria, was commoner in NASH than controls and there was no correlation between bacterial colony count and bacterial type and anthropometric and biochemical parameters.

NAFLD, Helicobacter species and the intestinal microbiome.

Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes

Multiple linear regression analysis showed that body mass index, glucose at 0 minutes, and SIBO were independently associated with the early-phase and total-phase insulin secretion and may be involved in lower levels of insulin release and worse glycemic control.

Non-Alcoholic Fatty Liver Disease, an Overview.

Weight loss and dietary modifications are currently the only recommendations provided to NAFLD patients, and there is histological improvement seen in patients whom lose 5-10% of their body weight.

References

SHOWING 1-10 OF 42 REFERENCES

High Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity: A Contributor to Severe Hepatic Steatosis

In morbidly obese patients, bacterial overgrowth prevalence is higher than in healthy subjects and is associated with severe hepatic steatosis.

Nonalcoholic fatty liver disease in patients with type 2 diabetes.

Increased Orocecal Transit Time in Patients with Nonalcoholic Fatty Liver Disease

Evidence of deranged intestinal motility in nondiabetic patients with NAFLD is shown and support the hypothesis that NA FLD could be linked to endotoxin-induced liver damage of intestinal origin.

Non-alcoholic fatty liver disease: The diagnosis and management.

NAFLD is associated with obesity and insulin resistance and is considered the hepatic manifestation of the metabolic syndrome, a combination of medical conditions including type 2 diabetes mellitus, hypertension, hyperlipidemia, and visceral adiposity.

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

Readily available clinical and laboratory variables can predict advanced fibrosis in adults with NAFLD, but additional information is needed to reliably predict the presence and severity of NASH.

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

Family history of diabetes, especially among nondiabetics, is associated with NASH and fibrosis in NAFLD, and diabetes is strongly associated with risk of NASH, fibrosis, and advanced fibrosis.

Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome.

Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8

NASH patients have a higher prevalence of small intestinal bacterial overgrowth which is associated with enhanced expression of TLR-4 and release of IL-8, and SIBO may have an important role in NASH through interactions with TLR -4 and induction of the pro-inflammatory cytokine, IL- 8.

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.

A concise overview of the role of liver biopsy versus noninvasive diagnostic tools for the differentiation of fatty liver from nonalcoholic steatohepatitis as well as for the determination of presence and extent of fibrosis is provided.

Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Only a "breath test" with lactulose can provide a differential diagnosis between IBS and SIBO, with almost identical symptoms; the use of non-absorbable antibiotics may be useful to reduce the degree of SIBO and related symptoms; it must be accompanied by the correction of the wrong alimentary habits underlying SIBO.